72 related articles for article (PubMed ID: 19656639)
1. Clinically important interaction between statin drugs and Clostridium difficile toxin?
McGuire T; Dobesh P; Klepser D; Rupp M; Olsen K
Med Hypotheses; 2009 Dec; 73(6):1045-7. PubMed ID: 19656639
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
3. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients.
Aseeri M; Schroeder T; Kramer J; Zackula R
Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for community-associated Clostridium difficile--Connecticut, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):340-3. PubMed ID: 18385641
[TBL] [Abstract][Full Text] [Related]
5. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
[TBL] [Abstract][Full Text] [Related]
7. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
Tunçcan OG; Ulutan F; Karakuş R
Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
[TBL] [Abstract][Full Text] [Related]
8. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
[TBL] [Abstract][Full Text] [Related]
9. A study of Clostridium difficile-associated disease at King Chulalongkorn Memorial Hospital, Thailand.
Pupaibool J; Khantipong M; Suankratay C
J Med Assoc Thai; 2008 Jan; 91(1):37-43. PubMed ID: 18386542
[TBL] [Abstract][Full Text] [Related]
10. Emergence of Clostridium difficile-associated disease in North America and Europe.
Kuijper EJ; Coignard B; Tüll P; ; ;
Clin Microbiol Infect; 2006 Oct; 12 Suppl 6():2-18. PubMed ID: 16965399
[TBL] [Abstract][Full Text] [Related]
11. Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation.
Vesta KS; Wells PG; Gentry CA; Stipek WJ
Am J Infect Control; 2005 Oct; 33(8):469-72. PubMed ID: 16216661
[TBL] [Abstract][Full Text] [Related]
12. [Clostridium difficile toxin A and other enteropathogens in stool specimens of children hospitalized due to acute diarrhoea].
Rozkiewicz D; Zaremba ML; Fiedoruk K; Daniluk T; Sciepuk M; Kurzatkowska B; Sulik A; Ołdak E
Przegl Epidemiol; 2005; 59(3):711-21. PubMed ID: 16433313
[TBL] [Abstract][Full Text] [Related]
13. Established and potential risk factors for Clostridum difficile infection.
Vaishnavi C
Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
[TBL] [Abstract][Full Text] [Related]
14. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.
Pépin J; Saheb N; Coulombe MA; Alary ME; Corriveau MP; Authier S; Leblanc M; Rivard G; Bettez M; Primeau V; Nguyen M; Jacob CE; Lanthier L
Clin Infect Dis; 2005 Nov; 41(9):1254-60. PubMed ID: 16206099
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-associated diarrhoea in patients with human immunodeficiency virus infection: a case-control study.
Tumbarello M; Tacconelli E; Leone F; Cauda R; Ortona L
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):259-63. PubMed ID: 7743309
[TBL] [Abstract][Full Text] [Related]
17. Toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Fanning S; Kyne L
Int J Infect Dis; 2007 Jan; 11(1):5-10. PubMed ID: 16857405
[TBL] [Abstract][Full Text] [Related]
18. Do statins protect against the development of Clostridium difficile-associated diarrhoea?
Nseir W; Bishara J; Mograbi J; Mahamid M; Khalaila W; Taha M; Farah R
J Antimicrob Chemother; 2013 Aug; 68(8):1889-93. PubMed ID: 23563740
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics.
Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M
Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]